Aptevo Therapeutics Inc. (APVO) vs 60 Degrees Pharmaceuticals Inc. (SXTP)

Aptevo Therapeutics Inc. and 60 Degrees Pharmaceuticals Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. and 60 Degrees Pharmaceuticals Inc. are of similar size ($3.2M and $3.1M). 60 Degrees Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Aptevo Therapeutics Inc. trades at 0.0×. Aptevo Therapeutics Inc. grew revenue faster over the last twelve months: 92.9% against 23.4%. Aptevo Therapeutics Inc. has the higher net margin (0.00% vs −650.3%) and the higher return on invested capital (0.00% vs −348.6%). Across the 16 metrics below, Aptevo Therapeutics Inc. leads on 10 and 60 Degrees Pharmaceuticals Inc. on 6.

Valuation

Metric APVO SXTP Biotechnology median
P/E 0.00 n/m 8.50
P/S 0.15 1.88 9.71
P/B 0.32 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.17 n/m 0.64
EV/Sales (0.34) 2.04 9.21
Earnings yield 100,773.33% (252.37%) (33.15%)
Free cash flow yield (1,315.16%) (397.08%) (25.50%)

Profitability

Metric APVO SXTP Biotechnology median
Gross margin 0.00% 43.42% 65.16%
Operating margin 0.00% (691.33%) 0.00%
Net margin 0.00% (650.34%) 0.00%
Free cash flow margin 0.00% (745.93%) 0.00%
Return on equity (446.89%) 110.82% (56.36%)
Return on assets (186.29%) (186.70%) (48.04%)
Return on invested capital 0.00% (348.64%) 0.00%

Growth

Metric APVO SXTP Biotechnology median
Revenue growth (TTM) 92.94% 23.41% 6.02%
EPS growth (last fiscal year) 99.72% 84.19% 30.26%
Revenue growth, 5-year CAGR (26.64%) (11.18%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO SXTP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 2.32 4.72
Net debt to EBITDA 0.83 0.37 0.96

Dividend

Metric APVO SXTP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric APVO SXTP Biotechnology median
Market cap 3.08m 3.17m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack